Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
lyofiliseret pulver til injicerbar opløsning |
Is a |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely degarelix 80 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely degarelix 120 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Cefazolin (as cefazolin sodium) 10 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefazolin (as cefazolin sodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefmetazolnatrium 2 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
benzylpenicillin, benzathin 150.000 IE + benzylpenicillin, procain 150.000 IE pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
benzylpenicillin, benzathin 900.000 IE/benzylpenicillin, procain 300.000 IE pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
hepatitis B-immunglobulin 200 IE pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely mitomycin 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely bleomycin (as bleomycin sulfate) 30 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
hepatitis B-immunglobulin 500 IE pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Anidulafungin 50 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefmetazolnatrium 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Trastuzumab 440 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely telavancin (as telavancin hydrochloride) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
hydrocortison 100 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefotetan (as cefotetan disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Hyaluronidase 1500 unit powder for solution for injection ampule |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
warfarin 2 mg/ml, pulver til injektionsvæske, opløsning |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Streptomycin (as streptomycin sulfate) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely pemetrexed (as pemetrexed disodium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
metronidazolhydrochlorid 500 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
digoxinspecifikt antistof 38 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
human alpha1-proteinasehæmmer 1000 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefapirinnatrium 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Agalsidase beta 5 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
natriumnitroprussid 50 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefazolin 250 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
varicella zoster-immunglobulin 125 IE pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefotetandinatrium 10 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
ceftazidim 3 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Aztreonam 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
ticarcillin 3 g + clavulansyre 100 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
L-asparaginase 10.000 IE pulver til injektionsvæske, opløsning, hætteglas a 10 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Piperacillin (as piperacillin sodium) 3 g and tazobactam (as tazobactam sodium) 375 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Aztreonam 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
metaiodobenzylguanidin[131I] 37 MBq/ml pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
natriumiodid[131I] 37-7400 MBq pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ampicillin (as ampicillin sodium) 2 gram and sulbactam (as sulbactam sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
faktor VIII 500 IE/von Willebrand-faktor 1250 IE, pulver til injektionsvæske, opløsning |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
azathioprin 50 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
6-[131I]Iodomethylnorcholesterol 8-30 MBq/ml, pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Nafcillin (as nafcillin sodium) 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
doripenem 500 mg, pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
kromphosphat[32P] 185 MBq/ml pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
metaiodobenzylguanidin[123I] 74 MBq/ml pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
gentamicin 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefepime (as cefepime hydrochloride) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
humant choriongonadotropin 10.000 IE pulver og solvent til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Polymyxin B sulfate 500,000u powder for injection solution vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
faktor VIII 1000 IE/von Willebrand-faktor 2500 IE, pulver til injektionsvæske, opløsning |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
bacitracin 5.000.000 enheder, pulver til injektionsvæske, opløsning, flaske |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
ceftazidim 250 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Aztreonam 2 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
rhenium[186Re]-etidronat 1,3 GBq/ml pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
ticarcillindinatrium 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely dactinomycin 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
omeprazol 40 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Rilonacept 220mg powder for injection solution 20ml vial |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefazolin (as cefazolin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
cefoxitinnatrium 10 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely romiplostim 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Cefazolin (as cefazolin sodium) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely bleomycin (as bleomycin sulfate) 15 unit/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
urokinase 250.000 IE pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Urea 40g powder for injection solution 200mL bottle |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
ticarcillindinatrium 20 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
folinsyre 15 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
folinsyre 30 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Amobarbital sodium 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Capreomycin (as capreomycin sulfate) 1 g powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
ticarcillindinatrium 3 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
azithromycin 500 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Palifermin 6.25 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Chlorothiazide 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
meropenem 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
abatacept 250 mg pulver til injektionsvæske, opløsning, hætteglas a 15 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
faktor IX-koncentrat 1000 IE, pulver til injektionsvæske, opløsning, hætteglas a 20 ml |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Remifentanil (as remifentanil hydrochloride) 2 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
thyrotropin alfa 0,9 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely remifentanil (as remifentanil hydrochloride) 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely cefamandole (as cefamandole nafate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
meropenem 500 mg pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
piperacillin 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Pentamidine isetionate 300 mg powder for solution for injection vial |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|
ceftizoximnatrium 1 g pulver til injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
False |
Powder for solution for injection |
Inferred relationship |
Some |
|
Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has manufactured dose form |
True |
Powder for solution for injection |
Inferred relationship |
Some |
|